Home » About Reapplix » Executive Management

EXECUTIVE MANAGEMENT

Kira Rupprecht Reapplix Chief Executive Officer

KIRA RUPPRECHT

CHIEF EXECUTIVE OFFICER

+1 949 294-0806 kr@reapplix.com

Kira has been appointed Chief Executive Officer for Reapplix in May 2021. Prior to joining Reapplix, Kira successfully introduced new wound care growth platforms as Head of Global Marketing and a member of the global management board at Urgo Medical. Under her leadership, Urgo Medical grew to become the second-largest advanced wound care company in Europe. Kira has over a decade of experience in various marketing roles in the medical device and biologics space both at Johnson & Johnson and Allergan in the US and Europe. In addition to healthcare, she has experience working in financial services at JP Morgan Chase.

Kira has an MBA from Harvard Business School and a BA in Economics and International Relations from Brown University.

CARSTEN HEINZE

CHIEF OPERATING OFFICER

+45 25 44 83 57 ch@reapplix.com

Carsten brings extensive experience from working in international organisations within Pharmaceutical, Medical Device and Biotech. He has an Executive MBA and a degree in Chemical Engineering and has for more than 25 years been working within Manufacturing and Supply Chain for Novo Nordisk, Dako, Exiqon and Ferrosan Medical Devices. Carsten joined Reapplix October 2021.

RASMUS LUNDQUIST

CHIEF SCIENTIFIC OFFICER

+45 26 71 74 47 rl@reapplix.com

Rasmus has a MSc. in biology and immunology from Copenhagen University and a graduate certificate in Biodesign from Stanford University. He is highly experienced in working with the development of in-vitro assays for the characterization of growth factor containing products. He analyzed chronic wound fluid by microarray technology at Copenhagen Wound Healing Center and Van Andel Research Institute, MI, USA. He is an experienced entrepreneur and co-founded RAM Biotech Aps in 2001 prior to his involvement with Reapplix. His exceptional skills have been a key factor in characterizing LeucoPatch® – now named 3C Patch® – and guiding the product development, clinical and product positioning activities. He is a founder of Reapplix.

MORTEN HAVE RASMUSSEN

CHIEF FINANCIAL OFFICER

+45 253 64 74 47 mhr@reapplix.com
Morten is an executive with background in finance and audit. Professional experience includes 4 years as audit manager at KPMG C. Jespersen and more than 12 years group finance experience from companies listed on Nasdaq Copenhagen. In the period 2011-2018 he held positions as Director of Finance for the life science companies Exiqon and QIAGEN. Morten has a M.Sc in Business Economics & Auditing (Cand. Merc. Aud.) from Copenhagen Business School. Morten joined Reapplix in February 2018.

Christian Vollmar VP Global Marketing & European Sales

DANIEL ANDREWS

VP SALES & HEALTHCARE SYSTEMS

+1 215-208-5713 dfa@reapplix.com

Daniel has over 15+ years of wound care leadership experience in sales, marketing, and strategic accounts. His team has been responsible for a wide portfolio of wound care technologies including regenerative tissue, negative pressure wound therapy, remote patient monitoring, advanced wound dressings, and debridement solutions.

Daniel has successfully launched new divisions and wound care technologies while working for a start-up organization and most recently Smith & Nephew, a global leader in the medical device industry.